Emerging Markets Mean Financial Rewards for the Life Sciences Industry
- 11/05/2015
New Challenges for Regulatory Compliance With healthcare spending on home soil drying up, and the UK National Health Service (NHS) set to achieve unprecedented efficiency savings of £50bn by 2020 (NHS England 2013), savvy UK life sciences firms are looking to emerging markets for growth. Unlike the UK, emerging markets are becoming increasingly appealing, due to a growing middle class
READ MORE